| 期刊全稱 | Antiphospholipid Syndrome | | 期刊簡稱 | Current Research Hig | | 影響因子2023 | Doruk Erkan,Michael D. Lockshin | | 視頻video | http://file.papertrans.cn/159/158644/158644.mp4 | | 發(fā)行地址 | A comprehensive and thorough collection of essays on all aspects of APS by internationally recognized authorities in the field.Presents the latest state-of-the-art information about evidence-based pra | | 圖書封面 |  | | 影響因子 | This new edition is a comprehensive and updated resource on antiphospholipid syndrome (APS), which is an autoimmune disorder. In APS, the body recognizes certain normal components of blood and/or cell membranes as foreign substances and produces antibodies (antiphospholipid antibodies) against them. APS is associated with recurrent clotting events (thrombosis) including premature stroke, repeated miscarriages, phlebitis, venous thrombosis, and pulmonary thromboembolism. It is also associated with low platelet or blood elements that prevent bleeding. Recently, however, even more disease states have been linked with APS, including premature heart attack, various cardiac valvular abnormalities, skin lesions, kidney disease, abnormal involuntary movement/chorea, diseases that mimic multiple sclerosis, and vascular diseases of the eye that can lead to visual loss and blindness. The International Congress on Antiphospholipid Antibodies, held every 3 years, is the venue where representativesfrom different disciplines gather to discuss the recent advances in APS. The conference intends to cover basic aspects of APS, such as pathogenesis, origins, genetics, intracellular and molecular event | | Pindex | Book 2017 |
The information of publication is updating
|
|
|Archiver|手機(jī)版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2026-1-17 02:28
發(fā)表于 2025-3-21 18:39:22
